DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
du BoisA, Vergote I, Ferron G. et al.
Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20. ASCO 2017.
J Clin Oncol; 2017
35. Abstr. 5501
Access:
We do not assume any responsibility for the contents of the web pages of other providers.